HYFT (MindWalk Holdings Inc.) Total Net Assets

Public company logo of MindWalk Holdings Inc. (HYFT)

MindWalk Holdings (HYFT) focuses on creating breakthrough LLMs for medicine and the active development of therapeutic IT systems. The business relies on unique drug discovery algorithms through metabolome analysis, which establishes a robust patent barrier. As reflected in the chart, the asset value is currently fixed at 0.00. A platform for corporate process optimization and data analysis provides additional stability.

HYFT - MindWalk Therapeutics Book Capitalization over the range 09/05/2025 - 10/30/2026
Mass-produced product of MindWalk Holdings, Inc.

Investors are evaluating the potential of MindWalk Holdings (HYFT) through the lens of tangible assets, where the difference between total liabilities and all obligations reveals the net business value. An analysis of the company's book value of equity allows market participants to filter out noise and see how investments in the AI biomarker discovery platform convert into actual growth of the issuer's assets, determining the fundamental stability of the stock.

Competitor analysis for MindWalk Holdings

Net Asset Value HLN|KVUE (Kenvue Inc.) - Company Net Assets|VRNA: Total Net Assets|Company Book Value Jyong Biotech|Ligand Pharmaceuticals Incorporated - Net Asset Value|Book Capitalization AMRX|PRGO (Perrigo Corp) - Accounting Value of Company|Book Capitalization ALVO (Alvotech)|Book Capitalization liquidia.com LQDA|GLPG - Company Book Value|Accounting Value of Company ANIP (ANI Pharmaceuticals Inc)|MannKind Corp. (MNKD) - Company Book Value|Company Net Assets Amphastar Corp|PCRX (Pacira BioSciences) - Book Capitalization|Book Capitalization ars-pharma.com|Company Net Assets TBPH (Theravance Biopharma, Inc.)|AQST (Aquestive Therapeutics Inc) - Accounting Value of Company|Company Book Value scPharmaceuticals SCPH|Tectonic Therapeutic Inc. (TECX) - Total Stockholders' Equity|TNXP: Company Net Assets|China SXT Pharmaceuticals - Total Net Assets|EPRX: Book Capitalization|BioHarvest Sciences, Inc. - Accounting Value of Company|EXOZ (Invizyne Technologies, Inc.) - Book Capitalization|Total Stockholders' Equity Oramed Pharma ORMP|Company Book Value Entera Bio Ltd. (ENTX)|ABVC (abvcpharma.com) - Accounting Value of Company|Company Book Value Cumberland Pharmaceuticals Inc. CPIX|QNTM - Company Net Assets|FibroGen Corp - Book Capitalization|Book Valuation of Business Telomir Pharmaceuticals Corp TELO|ranitherapeutics.com (RANI) - Company Book Value|Accounting Capitalization SNYR|RLYB (Rallybio Corp) - Book Capitalization|Accounting Capitalization LEXX (Lexaria)|Company Net Assets PULM (Pulmatrix Corp)|Company Net Assets ftzy.com.cn PTHL|Book Capitalization APM (Aptorum Group)|Book Capitalization lyratherapeutics.com LYRA|IBO - Company Book Value|TNFA: Company Book Value|cbdmd.com (YCBD) - Company Book Value|PainReform Corp (PRFX) - Book Capitalization|Company Net Assets CYTO|LIPO: Accounting Value of Company|Book Capitalization OPTN|PIRS (Pieris Pharmaceuticals Inc) - Accounting Value of Company|Company Book Value Procaps Group SA PROC|Petros Pharma (PTPI) - Total Stockholders' Equity|QLI - Company Book Value|SLRN: Company Book Value|TFFP: Book Capitalization